An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism.
Haas
S
S
Institute for Experimental Surgery, Technical University, Munich, FRG.
Blümel
G
G
D001842:Bone and Bones / Q000601:surgery; D004087:Dihydroergotamine / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D011183:Postoperative Complications / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D013923:Thromboembolism / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D004087:Dihydroergotamine